Effective Immunomodulatory Treatment of Escherichia coli Experimental Sepsis with Thalidomide
Thalidomide, an agent which inhibits biosynthesis of tumor necrosis factor alpha (TNF-α) and which is used to treat a variety of chronic inflammatory conditions, was investigated as therapy for experimental sepsis. Sepsis was induced by intraperitoneal injection of 10(7) CFU of Escherichia coli per...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166096/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878503/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2445-2449.2003 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|